Mei Tang

机构：Daiichi Sankyo (United States) · ORCID：0000-0002-7294-0355

发表论文 23 篇 · 总被引 570 次 · h-index 11

代表论文

• Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20–44 years of age (2012 · Breast Cancer Research and Treatment · 被引 145)
• α 1 -Antitrypsin Gene Therapy Modulates Cellular Immunity and Efficiently Prevents Type 1 Diabetes in Nonobese Diabetic Mice (2006 · Human Gene Therapy · 被引 82)
• Effect of Depo-Medroxyprogesterone Acetate on Breast Cancer Risk among Women 20 to 44 Years of Age (2012 · Cancer Research · 被引 76)
• Association between ABO blood groups and clinical outcome of coronavirus disease 2019: Evidence from two cohorts (2020 · medRxiv · 被引 59)
• Clinical Pharmacology of the Antibody–Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors (2024 · Clinical Pharmacokinetics · 被引 39)
• Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55–74 years of age (2014 · Breast Cancer Research and Treatment · 被引 27)